Market Closed -
Börse Stuttgart
01:26:40 09/07/2024 am IST
|
5-day change
|
1st Jan Change
|
6.195
EUR
|
+3.77%
|
|
-2.13%
|
-8.44%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
127.5
|
380.2
|
79.26
|
60.86
|
18.85
|
30.37
|
-
|
Enterprise Value (EV)
1 |
113.2
|
298.9
|
66.05
|
-9.624
|
-32.04
|
30.37
|
30.37
|
P/E ratio
|
-1.34
x
|
-3.41
x
|
-0.55
x
|
-1.29
x
|
-0.4
x
|
-0.47
x
|
-0.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
21
x
|
59.8
x
|
7.05
x
|
15.6
x
|
-
|
-
|
-
|
EV / Revenue
|
21
x
|
59.8
x
|
7.05
x
|
15.6
x
|
-
|
-
|
-
|
EV / EBITDA
|
-16,47,066
x
|
-46,36,065
x
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-13,55,233
x
|
-41,04,126
x
|
-7,26,306
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
-
|
-
|
-
|
-
|
Price to Book
|
4.48
x
|
3.55
x
|
4.72
x
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
691
|
1,122
|
1,310
|
1,595
|
2,693
|
4,459
|
-
|
Reference price
2 |
184.5
|
339.0
|
60.50
|
38.15
|
7.000
|
6.810
|
6.810
|
Announcement Date
|
12/02/20
|
25/02/21
|
29/03/22
|
03/03/23
|
29/03/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
6.074
|
6.362
|
11.24
|
3.892
|
-
|
-
|
-
|
EBITDA
|
-77.39
|
-82.01
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-88.22
|
-96.23
|
-130.2
|
-81.71
|
-39.66
|
-49.18
|
-52.4
|
Operating Margin
|
-1,452.49%
|
-1,512.59%
|
-1,158.76%
|
-2,099.33%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-94.35
|
-104.3
|
-142.6
|
-44.82
|
-42.2
|
-50.65
|
-52.54
|
Net income
1 |
-94.35
|
-104.3
|
-142.6
|
-44.82
|
-42.2
|
-50.65
|
-52.54
|
Net margin
|
-1,553.29%
|
-1,639.85%
|
-1,268.73%
|
-1,151.64%
|
-
|
-
|
-
|
EPS
2 |
-138.0
|
-99.50
|
-109.5
|
-29.48
|
-17.35
|
-14.49
|
-7.570
|
Free Cash Flow
|
-94.06
|
-92.64
|
-109.1
|
-
|
-
|
-
|
-
|
FCF margin
|
-1,548.49%
|
-1,456.08%
|
-970.83%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/02/20
|
25/02/21
|
29/03/22
|
03/03/23
|
29/03/24
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
1.856
|
1.372
|
2.1
|
0.42
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-46.82
|
-30.91
|
-25.97
|
-14.57
|
-10.25
|
-11.68
|
-9.599
|
-8.762
|
-9.619
|
-11.93
|
-12
|
-12.5
|
-12.75
|
-
|
-
|
Operating Margin
|
-2,522.36%
|
-2,253.21%
|
-1,236.76%
|
-3,468.81%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-47.57
|
-32.94
|
-28.11
|
29.07
|
-12.84
|
-14.46
|
-10.41
|
-8.704
|
-8.627
|
-11.81
|
-12.5
|
-13.03
|
-13.3
|
-
|
-
|
Net income
1 |
-47.57
|
-32.94
|
-28.11
|
29.07
|
-12.84
|
-14.46
|
-10.41
|
-8.704
|
-8.627
|
-11.81
|
-12.5
|
-13.03
|
-13.3
|
-
|
-
|
Net margin
|
-2,562.93%
|
-2,400.95%
|
-1,338.62%
|
6,922.14%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-34.00
|
-22.50
|
-19.00
|
19.25
|
-7.970
|
-6.990
|
-4.360
|
-3.410
|
-2.990
|
-4.200
|
-4.405
|
-4.530
|
-2.550
|
-2.620
|
-2.000
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
29/03/22
|
16/05/22
|
11/08/22
|
08/11/22
|
03/03/23
|
09/05/23
|
04/08/23
|
13/11/23
|
29/03/24
|
14/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
14.3
|
81.3
|
13.2
|
70.5
|
50.9
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-94.1
|
-92.6
|
-109
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-140%
|
-161%
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-50.3%
|
-55.5%
|
-54.9%
|
-
|
-
|
-
|
-
|
Assets
1 |
187.6
|
188
|
259.8
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
41.10
|
95.50
|
12.80
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-136.0
|
-86.60
|
-
|
-
|
-
|
-
|
-
|
Capex
|
1.34
|
1.94
|
0.89
|
-
|
-
|
-
|
-
|
Capex / Sales
|
21.98%
|
30.52%
|
7.88%
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/02/20
|
25/02/21
|
29/03/22
|
03/03/23
|
29/03/24
|
-
|
-
|
Last Close Price
6.81
USD Average target price
18.33
USD Spread / Average Target +169.21% Consensus |
1st Jan change
|
Capi.
|
---|
| +57.48% | 82TCr | | -7.18% | 35TCr | | +15.37% | 32TCr | | +7.45% | 30TCr | | +13.62% | 24TCr | | +14.55% | 22TCr | | -0.33% | 22TCr | | +8.14% | 17TCr | | -2.99% | 16TCr |
Other Pharmaceuticals
|